Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBIT (2020 - 2025)

Stemtech's EBIT history spans 6 years, with the latest figure at -$339217.0 for Q3 2025.

  • For Q3 2025, EBIT rose 52.65% year-over-year to -$339217.0; the TTM value through Sep 2025 reached -$1.8 million, up 52.89%, while the annual FY2024 figure was -$2.4 million, 43.51% up from the prior year.
  • EBIT for Q3 2025 was -$339217.0 at Stemtech, down from -$300988.0 in the prior quarter.
  • Across five years, EBIT topped out at $33163.0 in Q4 2024 and bottomed at -$3.4 million in Q3 2022.
  • The 5-year median for EBIT is -$716470.0 (2024), against an average of -$878407.2.
  • The largest annual shift saw EBIT tumbled 593.0% in 2023 before it surged 102.32% in 2024.
  • A 5-year view of EBIT shows it stood at -$1.8 million in 2021, then soared by 76.27% to -$432237.0 in 2022, then crashed by 230.13% to -$1.4 million in 2023, then soared by 102.32% to $33163.0 in 2024, then tumbled by 1122.88% to -$339217.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's EBIT are -$339217.0 (Q3 2025), -$300988.0 (Q2 2025), and -$1.2 million (Q1 2025).